Bio-Path Holdings
Stock Forecast, Prediction & Price Target
Bio-Path Holdings Financial Estimates
Bio-Path Holdings Revenue Estimates
Bio-Path Holdings EBITDA Estimates
Bio-Path Holdings Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $21.60M Low: $21.60M High: $21.60M avg. 0% | Avg: $40.05M Low: $40.05M High: $40.05M avg. 85.37% | Avg: $39.84M Low: $39.84M High: $39.84M avg. -0.53% | Avg: $58.20M Low: $58.20M High: $58.20M avg. 46.08% |
Net Income
% change YoY
| $-10.43M N/A | $-13.83M -32.55% | $-16.07M -16.21% | Avg: $-14.07M Low: $-1.74M High: $-1.74M avg. 12.46% | Avg: $-14.24M Low: $-1.68M High: $-1.68M avg. -1.24% | Avg: $-1.62M Low: $-1.62M High: $-1.62M avg. 88.59% | Avg: $2.48M Low: $2.48M High: $2.48M avg. 252.64% |
EBITDA
% change YoY
| $-10.28M N/A | $-13.72M -33.46% | $-15.76M -14.85% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$31.04 N/A | -$38.03 -22.51% | -$33.64 11.54% | Avg: -$3.65 Low: -$3.65 High: -$3.65 avg. 89.14% | Avg: -$3.52 Low: -$3.52 High: -$3.52 avg. 3.56% | Avg: -$3.4 Low: -$3.4 High: -$3.4 avg. 3.40% | Avg: $5.19 Low: $5.19 High: $5.19 avg. 252.64% |
Operating Expenses
% change YoY
| $10.44M N/A | $13.90M 33.11% | $15.84M 13.97% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Bio-Path Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 88.11% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -1.74M, average is -14.07M and high is -1.74M.
What is Bio-Path Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 32.73% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $21.60M, average is $21.60M and high is $21.60M.
What is Bio-Path Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 87.19% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$3.65, average is -$3.65 and high is $-3.65.